Related Experiment Video
Updated: Jun 16, 2026

03:59
Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
Published on: January 10, 2019
Endoscopic thoracic sympathectomy for primary palmar hyperidrosis.
Arun Prasad1, Mudasir Ali, Sunil Kaul
1Department of Minimal Access Surgery, Apollo Hospital, Sarita Vihar, New Delhi 110044, India. surgerytimes@gmail.com
Surgical Endoscopy
|January 30, 2010
Summary
Endoscopic thoracic sympathectomy effectively treats palmar hyperhidrosis, significantly improving patients' quality of life. This procedure offers a safe and satisfying solution with minimal recurrence for excessive sweating.
Area of Science:
- Cardiothoracic Surgery
- Neurosurgery
- Dermatology
Background:
- Primary hyperhidrosis is excessive sweating unrelated to thermoregulation, impacting social and professional life.
- Commonly affects palms, armpits, soles, and face, often exacerbated by emotions and heat.
- Existing treatments include topical agents, iontophoresis, medications, botulinum toxin, and surgical options.
Purpose of the Study:
- To evaluate the efficacy and safety of video-assisted thoracoscopic T3 sympathectomy for palmar hyperhidrosis.
- To assess the impact of the procedure on patients' quality of life.
- To document postoperative outcomes and side effects.
Main Methods:
- A prospective study of 322 patients undergoing bilateral video-assisted thoracoscopic T3 sympathectomy between 1998 and 2007.
- Data collected via case histories and pre- and postoperative questionnaires.
- Statistical analysis using paired t-test and Wilcoxon test.
Main Results:
- Immediate cessation of palmar hyperhidrosis in all patients.
- Significant improvement in quality of life reported.
- Compensatory sweating occurred in 63% of patients (29% if mild cases excluded), the most common side effect.
Conclusions:
- Endoscopic thoracic sympathectomy is a safe and effective treatment for palmar hyperhidrosis with low morbidity and zero mortality.
- The procedure leads to high patient satisfaction and minimal recurrence rates (1%).
- Recommended as a primary treatment option for palmar hyperhidrosis.

